CUA Guideline on ADT: Adverse Events and Management Strategies [UPDATE 2022]
CUA Guideline on Androgen Deprivation Therapy: Adverse Events and Management Strategies [UPDATE 2022]
EDITORIAL COMMITTEE: Fred Saad, Ricardo Rendon, Armen Aprikian, Andrew Feifer, Andrea Kokorovic
By participating in this educational session, health care providers can expect to:
- Summarize the major adverse events (AEs) associated with conventional androgen deprivation therapy (ADT)
- Review the evidence-based strategies to mitigate the AEs associated with ADT in men with prostate cancer (PC)
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 1.5 hours of credit.
This program was made possible with financial support from Tolmar.